Pharmerica Corporation PMC
29.25 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
29.20 Day range 29.28
29.20 52-week range 29.28
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 2017 | Credit Suisse | Downgrade | Outperform | Neutral |
| Aug 2, 2017 | Barrington Research | Downgrade | Outperform | Underperform |
| Mar 14, 2016 | Credit Suisse | Initiated | — | Outperform |
| Mar 13, 2016 | UBS | Downgrade | — | Neutral |
| Feb 28, 2016 | Barclays | Maintained | — | Underweight |
| Nov 8, 2015 | Barclays | Maintained | — | Underweight |
| Aug 9, 2015 | UBS | Upgrade | — | Buy |
| May 7, 2015 | RBC Capital | Maintained | — | Sector Perform |
| Nov 19, 2014 | Barrington Research | Initiated | — | Outperform |
| Nov 6, 2014 | Barclays | Maintained | — | Underweight |
| Sep 10, 2014 | Goldman Sachs | Initiated | — | Neutral |
| Sep 2, 2014 | Cowen & Co. | Upgrade | — | Outperform |
| Jun 8, 2014 | KeyBanc | Maintained | — | Buy |
| May 1, 2014 | Barclays | Maintained | — | Underweight |
| Mar 11, 2014 | Credit Suisse | Upgrade | — | Outperform |
| Oct 3, 2013 | KeyBanc | Initiated | — | Buy |
| Jul 8, 2013 | Barclays | Downgrade | — | Underweight |
| Feb 10, 2013 | RBC Capital | Downgrade | — | Sector Perform |
| Apr 24, 2012 | UBS | Maintained | — | Neutral |